Open-label, Controlled, Randomized, Multicenter, Dose Escalation Study Evaluating the Safety, Tolerability, and Efficacy of Single or Multiple Applications of StrataGraft Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects
Phase of Trial: Phase II
Latest Information Update: 19 Mar 2018
At a glance
- Drugs Human skin replacement (Primary)
- Indications Burns; Wounds
- Focus Therapeutic Use
- Sponsors Stratatech
- 15 Mar 2018 Planned End Date changed from 1 Oct 2018 to 1 Feb 2020.
- 15 Mar 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Feb 2020.
- 24 Apr 2017 Status changed from not yet recruiting to recruiting.